However, when performing this same correlation analysis by the study group, significant correlations were only identified in individuals with T2D between Cystatin C levels, CD14 and CD26 and MetS components, and CD14 levels with glucose levels (Table 3), possibly due to a loss in the statistical power of the test. The gene discussed is CD14; the disease is metabolic syndrome.